These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 38361928)

  • 1. Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma.
    Gao Z; Azar J; Zhu H; Williams-Perez S; Kang SW; Marginean C; Rubinstein MP; Makawita S; Lee HS; Camp ER
    Front Immunol; 2024; 15():1324093. PubMed ID: 38361928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma.
    Merali N; Jessel MD; Arbe-Barnes EH; Ruby Lee WY; Gismondi M; Chouari T; O'Brien JW; Patel B; Osei-Bordom D; Rockall TA; Sivakumar S; Annels N; Frampton AE
    HPB (Oxford); 2024 Jul; 26(7):873-894. PubMed ID: 38729813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice.
    Delvecchio FR; Fincham REA; Spear S; Clear A; Roy-Luzarraga M; Balkwill FR; Gribben JG; Bombardieri M; Hodivala-Dilke K; Capasso M; Kocher HM
    Cell Mol Gastroenterol Hepatol; 2021; 12(5):1543-1565. PubMed ID: 34252585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
    Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
    J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy is associated with suppression of the B cell-centered immune landscape in pancreatic ductal adenocarcinoma.
    Rupp L; Dietsche I; Kießler M; Sommer U; Muckenhuber A; Steiger K; van Eijck CWF; Richter L; Istvanffy R; Jäger C; Friess H; van Eijck CHJ; Demir IE; Reyes CM; Schmitz M
    Front Immunol; 2024; 15():1378190. PubMed ID: 38629072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma.
    Ahmed A; Köhler S; Klotz R; Giese N; Hackert T; Springfeld C; Zörnig I; Jäger D; Halama N
    Oncoimmunology; 2022; 11(1):2027148. PubMed ID: 35127251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct Tertiary Lymphoid Structure Associations and Their Prognostic Relevance in HER2 Positive and Negative Breast Cancers.
    Liu X; Tsang JYS; Hlaing T; Hu J; Ni YB; Chan SK; Cheung SY; Tse GM
    Oncologist; 2017 Nov; 22(11):1316-1324. PubMed ID: 28701569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of intratumoral tertiary lymphoid structures in pancreatic ductal adenocarcinoma: cellular properties and prognostic significance.
    Zou X; Lin X; Cheng H; Chen Y; Wang R; Ma M; Liu Y; Dai Z; Tasiheng Y; Yan Y; Hou Q; Ding F; Chen H; Yu X; Wang X; Liu C
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders.
    Sidiropoulos DN; Shin SM; Wetzel M; Girgis AA; Bergman D; Danilova L; Perikala S; Shu DH; Montagne JM; Deshpande A; Leatherman J; Dequiedt L; Jacobs V; Ogurtsova A; Mo G; Yuan X; Lvovs D; Stein-O'Brien G; Yarchoan M; Zhu Q; Harper EI; Weeraratna AT; Kiemen AL; Jaffee EM; Zheng L; Ho WJ; Anders RA; Fertig EJ; Kagohara LT
    bioRxiv; 2024 Sep; ():. PubMed ID: 39386736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
    Connolly KA; Nader M; Joshi N
    Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic cancer: Emerging field of regulatory B-cell-targeted immunotherapies.
    Senturk ZN; Akdag I; Deniz B; Sayi-Yazgan A
    Front Immunol; 2023; 14():1152551. PubMed ID: 37033931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring prognostic and immunological characteristics of pancreatic ductal adenocarcinoma through comprehensive genomic analysis of tertiary lymphoid structures and CD8 + T-cells.
    Hu H; Xu Y; Zhang Q; Ai X; Wang T; Li H; Jin C; Ouyang C; Wu Z
    J Cancer Res Clin Oncol; 2024 Jun; 150(6):300. PubMed ID: 38850373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures in cancer: maturation and induction.
    Chen Y; Wu Y; Yan G; Zhang G
    Front Immunol; 2024; 15():1369626. PubMed ID: 38690273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.
    Zhang Y; Xu M; Ren Y; Ba Y; Liu S; Zuo A; Xu H; Weng S; Han X; Liu Z
    Mol Cancer; 2024 Apr; 23(1):75. PubMed ID: 38582847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
    Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
    Front Immunol; 2022; 13():962056. PubMed ID: 36189233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mature tertiary lymphoid structures are key niches of tumour-specific immune responses in pancreatic ductal adenocarcinomas.
    Kinker GS; Vitiello GAF; Diniz AB; Cabral-Piccin MP; Pereira PHB; Carvalho MLR; Ferreira WAS; Chaves AS; Rondinelli A; Gusmão AF; Defelicibus A; Dos Santos GO; Nunes WA; Claro LCL; Bernardo TM; Nishio RT; Pacheco AM; Laus AC; Arantes LMRB; Fleck JL; de Jesus VHF; de Moricz A; Weinlich R; Coimbra FJF; de Lima VCC; Medina TDS
    Gut; 2023 Oct; 72(10):1927-1941. PubMed ID: 37230755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infiltrating pattern and prognostic value of tertiary lymphoid structures in resected non-functional pancreatic neuroendocrine tumors.
    Zhang WH; Wang WQ; Han X; Gao HL; Xu SS; Li S; Li TJ; Xu HX; Li H; Ye LY; Lin X; Wu CT; Long J; Yu XJ; Liu L
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33055204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
    N J; J T; Sl N; Gt B
    Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer.
    Groen-van Schooten TS; Franco Fernandez R; van Grieken NCT; Bos EN; Seidel J; Saris J; Martínez-Ciarpaglini C; Fleitas TC; Thommen DS; de Gruijl TD; Grootjans J; Derks S
    J Immunother Cancer; 2024 Jul; 12(7):. PubMed ID: 38955417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.